How Much Do GLP-1 Medications Cost in 2026?
Brand-Name GLP-1 Pricing
The list price for name-brand GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro typically ranges from $900 to $1,400 per month for cash-paying patients. However, with commercial insurance and manufacturer savings cards, the out-of-pocket prices can often be drastically reduced in the short term.
Compounded GLP-1 Pricing
Compounding pharmacies legally synthesize and dispense active ingredients exactly like semaglutide and tirzepatide when a drug is on the FDA shortage list. These options typically run between $149 to $500 monthly, making them the most affordable route, although they lack explicit FDA safety approval stamps per batch.
Insurance Coverage for GLP-1 Medications
While many health plans readily cover GLP-1s for Type 2 Diabetes, weight-loss prescriptions are frequently denied or require exhaustive prior authorizations. The landscape is shifting with discussions regarding Medicare obesity coverage expansions likely impacting the broader market.
Projected Retatrutide Pricing
Analysts anticipate Eli Lilly will price Retatrutide similarly (or slightly above) current Tirzepatide formulations given its triple-agonist superiority and unmatched clinical weight loss averages. Early projections look at $1,000–$1,500/month at launch.
Frequently Asked Questions
How much does Ozempic cost per month without insurance?
The list price of Ozempic is approximately $935/month without insurance.
Is compounded semaglutide safe?
Compounded medications are prepared by licensed pharmacies but are not FDA-approved.
Will insurance cover retatrutide?
If FDA-approved for weight loss, insurance coverage will likely mirror current GLP-1 coverage patterns.
What is the cheapest way to get GLP-1 medication?
Compounded semaglutide from a telehealth provider is typically the most affordable at $149–350/month.
How much will retatrutide cost?
Retatrutide pricing has not been announced. Based on tirzepatide's launch pricing and the premium positioning of a triple-agonist, analysts project $1,000–1,500/month at launch.
Related Tools
Disclaimer:
Pricing estimates are based on analyst data and generalized US retail costs. Actual out-of-pocket values differ dramatically depending strictly on personal insurance status, deductibles, geography, and pharmacy choice.